Cronos Group Provides Bi-Weekly MCTO Status Update
31 déc. 2021 16h15 HE
|
Cronos Group Inc.
TORONTO, Dec. 31, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative...
Cronos Group Provides Bi-Weekly MCTO Status Update
17 déc. 2021 21h45 HE
|
Cronos Group Inc.
TORONTO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative...
Cronos Group Provides Bi-Weekly MCTO Status Update
03 déc. 2021 16h15 HE
|
Cronos Group Inc.
TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative...
Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter
19 nov. 2021 16h30 HE
|
Cronos Group Inc.
TORONTO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative...
Cronos Group Files Form 12b-25
09 nov. 2021 07h30 HE
|
Cronos Group Inc.
TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and...
Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire
29 oct. 2021 07h30 HE
|
Cronos Group Inc.
Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well Underway TORONTO, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...
Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy
20 oct. 2021 06h00 HE
|
Cronos Group Inc.
Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plantThe SPINACH...
Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids
23 août 2021 07h30 HE
|
Cronos Group Inc.
TORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which...
Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference
09 août 2021 17h00 HE
|
Cronos Group Inc.
TORONTO, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike...
Cronos Group Appoints Bob Madore as Chief Financial Officer
06 août 2021 07h33 HE
|
Cronos Group Inc.
TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment...